These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 15619466

  • 41. Levodopa effective parkinsonism associated with aqueductal stenosis: a case report and review of the literature.
    Asamoto S, Sugiyama H, Doi H, Yokochi M, Hirabayashi K, Tanaka S, Sugiura K, Nakama H, Matsumoto K.
    No Shinkei Geka; 1998 Dec; 26(12):1089-92. PubMed ID: 9883448
    [Abstract] [Full Text] [Related]

  • 42. [Parkinson disease of juvenile onset with systemic lupus erythematosus in a pre-symptomatic stage].
    Chacón J, García-Moreno JM, Valencia J, Redondo L, Alegre S, Castro A, Pérez G.
    Rev Neurol; 1998 Dec; 29(8):725-7. PubMed ID: 10560105
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Superior divisional oculomotor nerve palsy caused by midbrain neurocysticercosis.
    Chotmongkol V, Sawanyawisuth K, Limpawattana P, Phuphatham A, Chotmongkol R, Intapan PM.
    Parasitol Int; 2006 Sep; 55(3):223-5. PubMed ID: 16737842
    [Abstract] [Full Text] [Related]

  • 45. The variability of levodopa response in Parkinson's disease: is sensitization reversible?
    Jabre MG, Bejjani BP.
    Mov Disord; 2008 Apr 30; 23(6):924; author reply 925. PubMed ID: 18163452
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Parkinsonism after lethargic encephalitis: possibly the first Spanish case in the second half of the century].
    Guitera V, Berciano J, Fernández JM, Pascual J.
    Neurologia; 1996 Jan 30; 11(1):37-40. PubMed ID: 8714176
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Treatment of intramedullary spinal cysticercosis: report of 2 cases and review of literature.
    Ahmad FU, Sharma BS.
    Surg Neurol; 2007 Jan 30; 67(1):74-7; discussion 77. PubMed ID: 17210306
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Anticysticercal treatment and seizures in neurocysticercosis.
    Singh G, Sander JW.
    Lancet Neurol; 2004 Apr 30; 3(4):207-8. PubMed ID: 15039032
    [No Abstract] [Full Text] [Related]

  • 57. [Infectious ventriculitis in relation with neurocysticercosis in Burkina Faso].
    Napon C, Maïga Y, Diallo O, Kaboré J.
    Rev Neurol (Paris); 2011 Apr 30; 167(8-9):632-4. PubMed ID: 21481903
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Amaurosis fugax caused by neurocysticercosis.
    Singhi P, Saini AG, Sankhyan N.
    Pediatr Infect Dis J; 2014 Apr 30; 33(4):427. PubMed ID: 24632665
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.